VIEZION Project

Combining targeted therapy, stem cells, and PIF to improve cancer patient outcomes.

Advancing Post-Surgical Cancer Treatment

Launched in 2016, the VIEZION Project combines targeted chemotherapy, stem cell therapy, and Preimplantation Factor (PIF) therapy to improve post-surgical outcomes for cancer patients by strengthening natural immunological responses and supporting tissue regeneration. This innovative approach directly led to the creation of the International Oncology Board, led by Prof. Jalid Sehouli (Charité University Hospital, Berlin), which brings together oncological specialists from different countries to share knowledge, discuss complex cases, and provide international second opinions to patients worldwide. Through this collaborative model, patients with challenging diagnoses can access expertise from multiple specialists across different continents, ensuring that treatment decisions benefit from diverse perspectives and the latest scientific knowledge.